US Stock MarketDetailed Quotes

WST West Pharmaceutical Services

Watchlist

316.590
-4.290-1.34%

Close Nov 22 16:00 ET

316.590
0.0000.00%

Post 16:41 ET

22.93BMarket Cap46.97P/E (TTM)

West Pharmaceutical Services Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-21.73%180.1M

-2.48%165M

-14.41%118.2M

7.24%776.4M

3.55%239M

36.23%230.1M

-2.25%169.2M

-8.66%138.1M

23.97%724M

43.53%230.8M

Net income from continuing operations

-15.69%136M

-28.24%111.3M

-17.64%115.3M

1.28%593.4M

33.01%137M

33.75%161.3M

-17.72%155.1M

-19.45%140M

-11.47%585.9M

-30.26%103M

Operating gains losses

----

-125.87%-5.2M

45.28%-16.8M

--0

--2.2M

--9.4M

2,612.50%20.1M

-1,946.67%-30.7M

Depreciation and amortization

12.61%40.2M

14.08%38.9M

12.66%35.6M

13.85%137.3M

15.43%35.9M

19.80%35.7M

13.29%34.1M

6.76%31.6M

-1.39%120.6M

-9.59%31.1M

Deferred tax

----

221.75%37.5M

----

28.21%-30.8M

----

Other non cash items

-90.91%-2.1M

33.90%-3.9M

43.08%-3.7M

-92.48%1M

-53.53%14.5M

82.54%-1.1M

-43.90%-5.9M

13.33%-6.5M

1,050.00%13.3M

82.46%31.2M

Change In working capital

-100.40%-100K

155.73%14.1M

26.07%-34.6M

-36.00%-20.4M

-76.75%26.9M

177.02%24.8M

47.62%-25.3M

6.77%-46.8M

92.43%-15M

1,305.21%115.7M

-Change in receivables

----

111.24%4M

----

71.17%-35.6M

----

-Change in inventory

----

72.89%-13.5M

----

42.43%-49.8M

----

-Change in payables and accrued expense

----

257.14%4.4M

----

-116.67%-2.8M

----

-Change in other current assets

----

-215.14%-21.3M

----

353.42%18.5M

----

-Change in other working capital

----

-89.03%6M

----

2,179.17%54.7M

----

Cash from discontinued investing activities

Operating cash flow

-21.73%180.1M

-2.48%165M

-14.41%118.2M

7.25%776.5M

3.60%239.1M

36.23%230.1M

-2.25%169.2M

-8.66%138.1M

23.97%724M

43.53%230.8M

Investing cash flow

Cash flow from continuing investing activities

14.21%-82.1M

-23.26%-101.2M

-10.35%-90.6M

-27.93%-368.7M

-14.77%-108.8M

-61.93%-95.7M

-24.39%-82.1M

-20.20%-82.1M

-13.87%-288.2M

-22.48%-94.8M

Capital expenditure reported

15.14%-81.3M

-32.89%-100.2M

-10.35%-90.6M

-27.20%-362M

-14.54%-108.7M

-65.74%-95.8M

-14.07%-75.4M

-24.77%-82.1M

-12.31%-284.6M

-24.05%-94.9M

Net business purchase and sale

----

--0

----

--0

----

Net other investing changes

-900.00%-800K

----

-86.11%-6.7M

-200.00%-100K

107.69%100K

----

-244.00%-3.6M

-92.31%100K

Cash from discontinued investing activities

Investing cash flow

14.21%-82.1M

-23.26%-101.2M

-10.35%-90.6M

-27.93%-368.7M

-14.77%-108.8M

-61.93%-95.7M

-24.39%-82.1M

-20.20%-82.1M

-13.87%-288.2M

-22.48%-94.8M

Financing cash flow

Cash flow from continuing financing activities

-188.79%-64.4M

-23.47%-218.3M

-281.69%-271M

-56.54%-459.6M

-1,894.74%-189.5M

70.35%-22.3M

-388.40%-176.8M

58.89%-71M

-74.66%-293.6M

-53.23%-9.5M

Net issuance payments of debt

-483.33%-3.5M

-4,580.00%-23.4M

0.00%-600K

94.81%-2.3M

0.00%-600K

98.59%-600K

0.00%-500K

0.00%-600K

-1,913.64%-44.3M

45.45%-600K

Net common stock issuance

-86.48%-52.4M

-7.34%-187.2M

-280.45%-272.4M

-103.06%-451.2M

-177,200.00%-177.1M

-2.18%-28.1M

-503.46%-174.4M

56.84%-71.6M

-46.28%-222.2M

200.00%100K

Cash dividends paid

-3.57%-14.5M

-3.55%-14.6M

-4.26%-14.7M

-5.36%-57M

-4.96%-14.8M

-3.70%-14M

-7.63%-14.1M

-5.22%-14.1M

-5.87%-54.1M

-6.02%-14.1M

Proceeds from stock option exercised by employees

-70.59%6M

-44.26%6.8M

9.80%16.8M

80.85%51M

-38.00%3.1M

142.86%20.4M

87.69%12.2M

84.34%15.3M

-23.99%28.2M

-39.76%5M

Net other financing activities

----

---100K

91.67%-100K

----

---1.2M

--100K

Cash from discontinued financing activities

Financing cash flow

-188.79%-64.4M

-23.47%-218.3M

-281.69%-271M

-56.54%-459.6M

-1,894.74%-189.5M

70.35%-22.3M

-388.40%-176.8M

58.89%-71M

-74.66%-293.6M

-53.23%-9.5M

Net cash flow

Beginning cash position

-43.97%446.2M

-32.10%601.8M

-4.52%853.9M

17.27%894.3M

23.26%898.6M

10.83%796.3M

32.74%886.3M

17.27%894.3M

23.90%762.6M

5.96%729M

Current changes in cash

-70.03%33.6M

-72.24%-154.5M

-1,522.67%-243.4M

-136.43%-51.8M

-146.80%-59.2M

223.99%112.1M

-226.52%-89.7M

83.30%-15M

-12.65%142.2M

63.86%126.5M

Effect of exchange rate changes

213.27%11.1M

-266.67%-1.1M

-224.29%-8.7M

208.57%11.4M

-62.63%14.5M

59.34%-9.8M

98.51%-300K

237.25%7M

33.12%-10.5M

1,592.31%38.8M

End cash Position

-45.37%490.9M

-43.97%446.2M

-32.10%601.8M

-4.52%853.9M

23.26%898.6M

10.83%796.3M

32.74%886.3M

17.27%894.3M

Free cash flow

-26.43%98.8M

-30.92%64.8M

-50.71%27.6M

-5.67%414.5M

-4.05%130.4M

20.88%134.3M

-12.34%93.8M

-34.43%56M

32.91%439.4M

61.21%135.9M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-21.73%180.1M	-2.48%165M	-14.41%118.2M	7.24%776.4M	3.55%239M	36.23%230.1M	-2.25%169.2M	-8.66%138.1M	23.97%724M	43.53%230.8M
Net income from continuing operations	-15.69%136M	-28.24%111.3M	-17.64%115.3M	1.28%593.4M	33.01%137M	33.75%161.3M	-17.72%155.1M	-19.45%140M	-11.47%585.9M	-30.26%103M
Operating gains losses	----	----	----	-125.87%-5.2M	45.28%-16.8M	--0	--2.2M	--9.4M	2,612.50%20.1M	-1,946.67%-30.7M
Depreciation and amortization	12.61%40.2M	14.08%38.9M	12.66%35.6M	13.85%137.3M	15.43%35.9M	19.80%35.7M	13.29%34.1M	6.76%31.6M	-1.39%120.6M	-9.59%31.1M
Deferred tax	----	----	----	221.75%37.5M	----	----	----	----	28.21%-30.8M	----
Other non cash items	-90.91%-2.1M	33.90%-3.9M	43.08%-3.7M	-92.48%1M	-53.53%14.5M	82.54%-1.1M	-43.90%-5.9M	13.33%-6.5M	1,050.00%13.3M	82.46%31.2M
Change In working capital	-100.40%-100K	155.73%14.1M	26.07%-34.6M	-36.00%-20.4M	-76.75%26.9M	177.02%24.8M	47.62%-25.3M	6.77%-46.8M	92.43%-15M	1,305.21%115.7M
-Change in receivables	----	----	----	111.24%4M	----	----	----	----	71.17%-35.6M	----
-Change in inventory	----	----	----	72.89%-13.5M	----	----	----	----	42.43%-49.8M	----
-Change in payables and accrued expense	----	----	----	257.14%4.4M	----	----	----	----	-116.67%-2.8M	----
-Change in other current assets	----	----	----	-215.14%-21.3M	----	----	----	----	353.42%18.5M	----
-Change in other working capital	----	----	----	-89.03%6M	----	----	----	----	2,179.17%54.7M	----
Cash from discontinued investing activities
Operating cash flow	-21.73%180.1M	-2.48%165M	-14.41%118.2M	7.25%776.5M	3.60%239.1M	36.23%230.1M	-2.25%169.2M	-8.66%138.1M	23.97%724M	43.53%230.8M
Investing cash flow
Cash flow from continuing investing activities	14.21%-82.1M	-23.26%-101.2M	-10.35%-90.6M	-27.93%-368.7M	-14.77%-108.8M	-61.93%-95.7M	-24.39%-82.1M	-20.20%-82.1M	-13.87%-288.2M	-22.48%-94.8M
Capital expenditure reported	15.14%-81.3M	-32.89%-100.2M	-10.35%-90.6M	-27.20%-362M	-14.54%-108.7M	-65.74%-95.8M	-14.07%-75.4M	-24.77%-82.1M	-12.31%-284.6M	-24.05%-94.9M
Net business purchase and sale	----	----	----	--0	----	----	----	----	--0	----
Net other investing changes	-900.00%-800K	----	----	-86.11%-6.7M	-200.00%-100K	107.69%100K	----	----	-244.00%-3.6M	-92.31%100K
Cash from discontinued investing activities
Investing cash flow	14.21%-82.1M	-23.26%-101.2M	-10.35%-90.6M	-27.93%-368.7M	-14.77%-108.8M	-61.93%-95.7M	-24.39%-82.1M	-20.20%-82.1M	-13.87%-288.2M	-22.48%-94.8M
Financing cash flow
Cash flow from continuing financing activities	-188.79%-64.4M	-23.47%-218.3M	-281.69%-271M	-56.54%-459.6M	-1,894.74%-189.5M	70.35%-22.3M	-388.40%-176.8M	58.89%-71M	-74.66%-293.6M	-53.23%-9.5M
Net issuance payments of debt	-483.33%-3.5M	-4,580.00%-23.4M	0.00%-600K	94.81%-2.3M	0.00%-600K	98.59%-600K	0.00%-500K	0.00%-600K	-1,913.64%-44.3M	45.45%-600K
Net common stock issuance	-86.48%-52.4M	-7.34%-187.2M	-280.45%-272.4M	-103.06%-451.2M	-177,200.00%-177.1M	-2.18%-28.1M	-503.46%-174.4M	56.84%-71.6M	-46.28%-222.2M	200.00%100K
Cash dividends paid	-3.57%-14.5M	-3.55%-14.6M	-4.26%-14.7M	-5.36%-57M	-4.96%-14.8M	-3.70%-14M	-7.63%-14.1M	-5.22%-14.1M	-5.87%-54.1M	-6.02%-14.1M
Proceeds from stock option exercised by employees	-70.59%6M	-44.26%6.8M	9.80%16.8M	80.85%51M	-38.00%3.1M	142.86%20.4M	87.69%12.2M	84.34%15.3M	-23.99%28.2M	-39.76%5M
Net other financing activities	----	----	---100K	91.67%-100K	----	----	----	----	---1.2M	--100K
Cash from discontinued financing activities
Financing cash flow	-188.79%-64.4M	-23.47%-218.3M	-281.69%-271M	-56.54%-459.6M	-1,894.74%-189.5M	70.35%-22.3M	-388.40%-176.8M	58.89%-71M	-74.66%-293.6M	-53.23%-9.5M
Net cash flow
Beginning cash position	-43.97%446.2M	-32.10%601.8M	-4.52%853.9M	17.27%894.3M	23.26%898.6M	10.83%796.3M	32.74%886.3M	17.27%894.3M	23.90%762.6M	5.96%729M
Current changes in cash	-70.03%33.6M	-72.24%-154.5M	-1,522.67%-243.4M	-136.43%-51.8M	-146.80%-59.2M	223.99%112.1M	-226.52%-89.7M	83.30%-15M	-12.65%142.2M	63.86%126.5M
Effect of exchange rate changes	213.27%11.1M	-266.67%-1.1M	-224.29%-8.7M	208.57%11.4M	-62.63%14.5M	59.34%-9.8M	98.51%-300K	237.25%7M	33.12%-10.5M	1,592.31%38.8M
End cash Position	-45.37%490.9M	-43.97%446.2M	-32.10%601.8M	-4.52%853.9M	-4.52%853.9M	23.26%898.6M	10.83%796.3M	32.74%886.3M	17.27%894.3M	17.27%894.3M
Free cash flow	-26.43%98.8M	-30.92%64.8M	-50.71%27.6M	-5.67%414.5M	-4.05%130.4M	20.88%134.3M	-12.34%93.8M	-34.43%56M	32.91%439.4M	61.21%135.9M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data